A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced sol... von Ghamande, Sharad, Lin, Chia-Chi, Cho, Daniel C., Shapiro, Geoffrey I., Kwak, Eunice L., Silverman, Michael H., Tseng, Yunlong, Kuo, Min-Wen, Mach, Wendy B., Hsu, Shu-Chi, Coleman, Teresa, Yang, James Chih-Hsin, Cheng, Ann-Lii, Ghalib, Mohammad H., Chuadhary, Imran, Goel, Sanjay

Volltext

Abstract A89: A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388 (Lipotecan®), administered intravenously to patients with advanced solid tumors von Ghamande, Sharad, Lin, Chia-Chi, Cho, Daniel C., Coleman, Teresa, Chaudhary, Imran, Shapiro, Geoffrey I., Silverman, Michael, Kuo, Min-Wen, Mach, Wendy B., Tseng, Yunlong, Kao, Min-Hsiung, Hsu, Shu Chi, Goel, Sanjay

Volltext

Pharmaceutical composition for inhibition of tumor growth or metastasis von LIN JUI Y, CHEN PO-HSUN, MACH WENDY B

Volltext bestellen

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type... von Casimiro, Danilo R, Chen, Ling, Fu, Tong-Ming, Evans, Robert K, Caulfield, Michael J, Davies, Mary-Ellen, Tang, Aimin, Chen, Minchun, Huang, Lingyi, Harris, Virginia, Freed, Daniel C, Wilson, Keith A, Dubey, Sheri, Zhu, De-Min, Nawrocki, Denise, Mach, Henryk, Troutman, Robert, Isopi, Lynne, Williams, Donna, Hurni, William, Xu, Zheng, Smith, Jeffrey G, Wang, Su, Liu, Xu, Guan, Liming, Long, Romnie, Trigona, Wendy, Heidecker, Gwendolyn J, Perry, Helen C, Persaud, Natasha, Toner, Timothy J, Su, Qin, Liang, Xiaoping, Youil, Rima, Chastain, Michael, Bett, Andrew J, Volkin, David B, Emini, Emilio A, Shiver, John W

Volltext